StockData
MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31

Medicenna Therapeutics Corp.

Financials through fiscal 2023, year ended Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)

Close on Oct 19, 2026

Medicenna Therapeutics Corp. revenue by segment

No segment breakdown reported

Medicenna Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.